StocksFin Logo
Sage Therapeutics, Inc. country of incorporation
|
|
Dr. Jeffrey Jonas
|
471 employees
NASDAQ | Healthcare | Biotechnology
Definitive Healthcare Corp. country of incorporation
|
|
676 employees
NASDAQ | Healthcare | Health Information Services
Q322 reported Nov 8, 2022 Reporting Period
$1.74M 20.8% vs. Q321 Revenues Q322
89.42% -1.6% vs. Q321 Gross Profit Margin
-1000% ! 0% vs. Q321 Net Profit Margin
-119.23M ! -73.2% vs. Q321 Free Cash Flow Q322
$-2.31 ! -4.5% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
0.1%
Q322 reported Nov 3, 2022 Reporting Period
$57.38M 33.2% vs. Q321 Revenues Q322
83.05% 9.8% vs. Q321 Gross Profit Margin
-4.69% ! 74.7% vs. Q321 Net Profit Margin
8.81M 1029% vs. Q321 Free Cash Flow Q322
$-0.03 ! 66.7% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
0.1%
Loading...
Loading...
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Sep 30, 2022
Quick Ratio
14.17
3.15
Current Ratio
14.7
3.31
Cash Ratio
2
1.88
Price to Book
1.69
1.71
Price to Sales
100
27.87
Price to Earnings
-4.24
-148.67